CC
Chongqing Chen'an Biopharmaceutical Co., Ltd
Manufacturer · Chongqing, China
Overview
Chongqing Chen'an Biopharmaceutical has worked since 2015 on drugs for diabetes, obesity and other metabolic diseases, with a site in Banan District, Chongqing. Chongqing Zhifei Biological Products (stock code 300122) took a controlling stake in 2025. Chen'an holds active US Type II DMFs for liraglutide and semaglutide.
Capabilities
- Peptide APIs
- GLP-1 drugs
- Metabolic disease pipeline
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |